Statistics
Publications
14
Citations
5.5K
H-Index
13
Active since
1993
David J. Dow is an author at GlaxoSmithKline (United Kingdom) specializing in life sciences, genetics, and genetic disorders.
Publications per year
1993–2019
14
14
Prioritization of cancer therapeutic targets using CRISPR–Cas9 screens
Fiona M. Behan, Francesco Iorio, Gabriele Picco et al. · Nature · 2019 · 1.4K citations · Full text
Lentiviral Hematopoietic Stem Cell Gene Therapy Benefits Metachromatic Leukodystrophy
Alessandra Biffi, Eugenio Montini, Laura Lorioli et al. · Science · 2013 · 1.2K citations · Full text
Life Sciences, Genetics, Hematology +16
Lentiviral Hematopoietic Stem Cell Gene Therapy in Patients with Wiskott-Aldrich Syndrome
Alessandro Aiuti, Luca Biasco, Samantha Scaramuzza et al. · Science · 2013 · 1K citations · Full text
Medicine, Cell Biology, Hematology +16
Genetic variations in HLA-B region and hypersensitivity reactions to abacavir
Seth Hetherington, Arlene R. Hughes, Michael Mosteller et al. · The Lancet · 2002 · 812 citations
A general method for the detection of large CAG repeat expansions by fluorescent PCR.
Jon Warner, L H Barron, David Goudie et al. · Journal of Medical Genetics · 1996 · 294 citations · Full text
1–5 of 14